Just three pharmacy benefit managers, Express Scripts, Caremark, and OptumRx, handle 80% of prescriptions in the U.S.
The Federal Trade Commission plans to sue the three largest pharmacy benefit managers in the country over practices that have kept drug prices artificially high, according to new reports from thePharmacy benefit managers, often abbreviated as PBMs, are essentially just middlemen who handle prescriptions for employers and insurers.
PBMs and are supposed to negotiate with the drug companies to get better prices for consumers, but critics allege they’re often doing the exact opposite, driving up prices without the proper incentives to get better deals for patients. The three largest pharmacy benefit managers in the country, Express Scripts, Caremark, and OptumRx, control roughly 80% of the 6.6 billion prescriptions filled each year, according to STAT, which also notes the companies didn’t provide all of the information requested by the FTC for its report released Tuesday. It appears that those three companies will be the only ones sued by the FTC, despite the fact that the next three are also relatively significant. The top six pharmacy benefit managers control 94% of the market, according to, and Express Scripts is owned by the insurance company Cigna. And it’s that kind of ownership that critics point out doesn’t allow for proper negotiations in the first place. The FTC may also go after the largest insulin manufacturers over the soaring costs that have been passed on to consumers over the past decade, according to the Wall Street Journal. Some legislators like Bernie Sanders have criticized the drug companies for their price-gouging, including the soaring cost of insulin in recent years. That scrutiny caused Lilly, Sanofi, and Novo Nordisk to all pledge lower insulin prices this year. The timing of the FTC’s possible lawsuit is unclear, based on the reports, and the agency didn’t immediately respond to questions emailed on Wednesday. For their part, pharmacy benefit managers have defended their work, with Caremark telling Gizmodo over email that the company, “is proud of the work we have done to make insulin more affordable for all Americans with diabetes,” and noting the price of insulin has come down. “Our members on average pay less than $25, far below list prices and far below the Biden Administration’s $35 cap,” David Whitrap, Vice President of External Affairs at Caremark, told Gizmodo. “Further, we also provide access to $25 insulin to every American, whether insured or uninsured, through our ReducedRx program at every one of our 67,000 network pharmacies and more than 9,000 CVS pharmacies.” Express Scripts and OptumRx didn’t immediately respond to questions emailed on Wednesday. Gizmodo will update this post if we hear back.Doctors and potential patients are hopeful about Wegovy, but is it really the miracle it's hyped up to be, and will it contribute to medical fatphobia?We’re Ready to Fall for This Adorable, Adventurous Skeleton
Please follow us on Google to support us United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FTC and State AGs Sue to Block Kroger-Albertsons 'Mega Merger'Jake Johnson is a senior editor and staff writer for Common Dreams.
Read more »
Prescription drug prices rose nearly 40% over last decade, surpassing inflation rate, tracker showsThe data from GoodRx showed patients are having increased difficulty navigating insurance hurdles, including increased costs and more restrictions on covered drugs.
Read more »
FTC to sue drug middlemen over prices of medications including insulinUnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts will reportedly be the targets of the FTC's suits.
Read more »
FTC to sue drug middlemen CVS, UnitedHealth over insulin prices: reportThe agency plans to file lawsuits targeting the business practices related to rebates brokered with drug manufacturers, the Journal reported.
Read more »
US FTC to Sue Drug Middlemen Over Insulin Prices, Source SaysThe U.S. Federal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health - the three largest pharmacy-benefit managers - over their tactics for negotiating...
Read more »
FTC poised to sue drug middlemen over insulin pricesThe planned suit would follow a two-year investigation by the agency.
Read more »